Clinical Trials in Skien, Norway
5 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled468 locationsNCT05485961
Recruiting
DESTINY Breast Respond HER2-low Europe
Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
Phase 4
Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)
Rheumatoid Arthritis
Diakonhjemmet Hospital350 enrolled22 locationsNCT06440629
Recruiting
Phase 3
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Prostate Cancer
Sven Löffeler980 enrolled18 locationsNCT05448547
Recruiting
The Norwegian Immunotherapy in Multiple Myeloma Study
Plasma Cell LeukemiaMyeloma, MultipleAL Amyloidosis
St. Olavs Hospital400 enrolled23 locationsNCT06855121
Recruiting
NORDTREAT Prospective Study on Inflammatory Bowel Disease
Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Diseases (IBD)
University of Southern Denmark800 enrolled17 locationsNCT05414578